TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Genoptix, Inc. Investor Investigation Questions Potential Unfairness Of Buyout Offer By Novartis

  • If you are a long term investor in Genoptix, Inc. (NASDAQ:GXDX) and currently hold those GXDX shares, and/or if you have any information relating the investigation, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

After Novartis announced that the Genoptix board of directors agreed to a buyout offer of $25 per share an investigation for investors of Genoptix, Inc. (NASDAQ:GXDX) over possible breaches of fiduciary duty was announced within hours. The investigation by a law firm concerns whether certain directors and officers at Genoptix, Inc. (NASDAQ:GXDX) will breach their fiduciary duties in ...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: